These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 37894344)

  • 1. Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma.
    Agirre-Lizaso A; Huici-Izagirre M; Urretabizkaia-Garmendia J; Rodrigues PM; Banales JM; Perugorria MJ
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tumor associated macrophages in hepatocellular carcinoma.
    Xu W; Cheng Y; Guo Y; Yao W; Qian H
    Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
    Xu L; Xie X; Luo Y
    Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking CX3CR1+ Tumor-associated Macrophages Enhances the Efficacy of Anti-PD-1 Therapy in Hepatocellular Carcinoma.
    Xiang X; Wang K; Zhang H; Mou H; Shi Z; Tao Y; Song H; Lian Z; Wang S; Lu D; Wei X; Xie H; Zheng S; Wang J; Xu X
    Cancer Immunol Res; 2024 Aug; ():. PubMed ID: 39115356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
    Zhou D; Luan J; Huang C; Li J
    Gut Liver; 2021 Jul; 15(4):500-516. PubMed ID: 33087588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages in liver cancer: From mechanisms to therapy.
    Cheng K; Cai N; Zhu J; Yang X; Liang H; Zhang W
    Cancer Commun (Lond); 2022 Nov; 42(11):1112-1140. PubMed ID: 36069342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
    Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
    J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
    Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
    Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
    Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
    J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Jul; ():. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 Oct; 81(4):690-703. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-155 regulates M2 polarization of hepatitis B virus-infected tumour-associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma.
    Fei Y; Wang Z; Huang M; Wu X; Hu F; Zhu J; Yu Y; Shen H; Wu Y; Xie G; Zhou Z
    J Viral Hepat; 2023 May; 30(5):417-426. PubMed ID: 36704832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy.
    Zheng H; Peng X; Yang S; Li X; Huang M; Wei S; Zhang S; He G; Liu J; Fan Q; Yang L; Li H
    Cell Death Discov; 2023 Feb; 9(1):65. PubMed ID: 36792608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma Cell-Derived Exosomal miR-21-5p Induces Macrophage M2 Polarization by Targeting RhoB.
    Yu H; Pan J; Zheng S; Cai D; Luo A; Xia Z; Huang J
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking siglec-10
    Xiao N; Zhu X; Li K; Chen Y; Liu X; Xu B; Lei M; Xu J; Sun HC
    Exp Hematol Oncol; 2021 Jun; 10(1):36. PubMed ID: 34112250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
    Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
    Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.